Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Reported Late Tuesday, AdaptHealth Provides FY23 Guidance And Preliminary Commentary On Q4 2022 Results; Sees FY23 Revenue $3.21B-$3.29B; Adj. EBITDA $690M-$750M; Sees FY22 Revenue To Be Near Midpoint Of Previous Guidance Of $2.95B-$3.01B

AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and

AHCO